SYNE1 -related autosomal recessive cerebellar ataxia, congenital cerebellar hypoplasia, and cognitive impairment

The spectrin repeat-containing nuclear envelope protein 1 ( ) gene encodes a family of spectrin structural proteins that are associated with anchoring the plasma membrane to the actin cytoskeleton. -related disease is most commonly reported in autosomal recessive spinocerebellar ataxia 8, which demo...

Full description

Saved in:
Bibliographic Details
Published inClinics and practice Vol. 8; no. 3; p. 1071
Main Authors Swan, Lauren, Cardinal, John, Coman, David
Format Journal Article
LanguageEnglish
Published Italy PAGEPress Publications, Pavia, Italy 27.08.2018
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The spectrin repeat-containing nuclear envelope protein 1 ( ) gene encodes a family of spectrin structural proteins that are associated with anchoring the plasma membrane to the actin cytoskeleton. -related disease is most commonly reported in autosomal recessive spinocerebellar ataxia 8, which demonstrates variable age of onset with a median of 30 years of age. However pathogenic mutations in are also causative of arthrogryposis multiplex congenital, a severe congenital neuromuscular condition. Here in we report monozygous twins with childhood onset ataxia, cerebellar hypoplasia, dysarthria, and cognitive impairment sharing two novel heterozygous mutations in the gene. Our family may expand the clinical phenotype associated with -related disease and offers possible genotype-phenotype correlations of a rare continuum of clinical disease phenotypes from neonatal to adult onset.
Bibliography:Conflict of interest: the authors declare no potential conflict of interest.
Contributions: LS, drafting of the manuscript, revision and review of the manuscript, and approval of the final manuscript as submitted. JC, revision and review of the manuscript, and approval of the final manuscript as submitted. JC and DC were involved in interoperating the genetic bioinformatics data. DC was the primary treating clinician; he conceptualized and designed the study, drafted the initial manuscript, and approved the final manuscript as submitted.
ISSN:2039-7275
2039-7283
2039-7283
DOI:10.4081/cp.2018.1071